Trial Details
TERMINATEDBasic Information
| Clinical ID | c1759 |
|---|---|
| Identifier | NCT03599622 |
| Trial Title | An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Granulomatous Colitis|Crohn's Disease|Crohn's Enteritis|Granulomatous Enteritis |
| Interventions | DRUG: BMS-986165|OTHER: Placebo |
Participant Information
| Sponsor | Bristol-Myers Squibb |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2018-07-16 |
|---|---|
| Primary Completion Date | 2022-12-12 |
| Completion Date | 2023-10-23 |